Psychedelic Science 2023

Be Part of

        the Breakthrough

Presented by

A conversation with Amanda Feilding and Rick Doblin, Ph.D.

PS2023-79-tn

A conversation with Amanda Feilding and Rick Doblin, Ph.D.

Speakers
Amanda Feilding is the Founder and Executive Director of the Beckley Foundation, and is widely recognised as a leading force behind the current Psychedelic Renaissance. By establishing key Research Programmes at some of the world’s most prestigious institutions (including Imperial College London, UCL, Maastricht University), she has propelled the field forward over the last 24 years, conducting landmark studies, such as the world’s first psilocybin for treatment-resistant depression study, the world’s first LSD, MDMA and DMT brain imaging studies, plus the initiation and collaboration with Johns Hopkins on the first study using psilocybin-assisted psychotherapy to overcome nicotine addiction. She has also co-authored over 80 research papers.

Share: A conversation with Amanda Feilding and Rick Doblin, Ph.D.

Facebook
Twitter
LinkedIn
Email

Already Registered?

If you already registered for the in-person portion of the Psychedelic Science 2023 conference, get immediate access to PS2023: The Virtual Trip by logging in with the email address you used when signing up for the conference. We’ll email you a login link—no password necessary!

Need to Register?

If you are not yet registered for Psychedelic Science 2023, you can sign up for PS2023: The Virtual Trip access by creating an account.